retatrutide nonalcoholic steatohepatitis nash trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Clinical Trial Landscape in NASH

For patients who discontinue GLP-1 medications or seek complementary approaches, several evidence-based alternatives exist

Whole grains like oatmeal, quinoa, and brown rice provide sustained energy along with fiber

Demographic data indicates that GLP-1 use spans diverse patient populations, though access remains uneven

Sakurai M, Nakamura K, Miura K, Takamura T, Yoshita K, Nagasawa SY, et al

Orobuccally administered glutathione Orobuccally administered glutathione is transported through the tissues lining the mouth and cheeks, allowing it to circumvent the hostile gastrointestinal environment altogether

Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al